MedTrace Logo

Effect of Starter Formula on Infection Prevention

NCT01880970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 477

Last updated 2015-10-21

No results posted yet for this study

Summary

The aim of this trial is to test the efficacy of an infant formula containing synbiotics on the prevention of gastro-intestinal infections.

Conditions

  • Gastro-intestinal Infections
  • Infections With Fever

Interventions

OTHER

starter infant formula with pro and prebiotics

OTHER

Placebo comparator

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Jean Michel Hascoet, Prof. · Maternité régionale de Nancy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • France
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01880970 on ClinicalTrials.gov